Quanterix (QTRX) vs Neuronetics (STIM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Neuronetics (STIM) has outperformed Quanterix (QTRX) over the past year, losing 27.9% versus a loss of 46.5%. Over five years, STIM leads with a -56.0% price change compared with -93.8% for QTRX. Neuronetics is the larger company by market cap ($163.1 million vs $151.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QTRX | STIM |
|---|---|---|
| Share price | $3.21 | $2.14 |
| Market cap | $151.81M | $163.06M |
| 1-day change | -3.46% | -1.38% |
| YTD return | -49.53% | +55.07% |
| 1-year return | -46.50% | -27.95% |
| 5-year return | -93.79% | -55.97% |
| EPS (TTM) | $-2.61 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.77 | $3.44 |
| 52-week low | $2.15 | $0.80 |
| Distance from 52-week high | -63.40% | -37.79% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | -6.54% | +168.69% |
| Average volume | 762.14K | 2.07M |
| Shares outstanding | 47.29M | 76.20M |
| Employees | 450 | 658 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STIM has outperformed QTRX by 18.6 percentage points over the past year.
- The two companies sit in different sectors: Quanterix in Industrials and Neuronetics in Health Care.
About Quanterix
QTRX stock →Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Industrials · Biotechnology: Laboratory Analytical Instruments · 450 employees
About Neuronetics
STIM stock →Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
Health Care · Medical/Dental Instruments · 658 employees
QTRX vs STIM FAQ
Which is bigger, Quanterix or Neuronetics?
Neuronetics (STIM) is larger, with a market capitalization of $163.06M compared with $151.81M for Quanterix (QTRX).
Which stock has performed better over the past year, QTRX or STIM?
STIM returned -27.95% over the past 12 months, compared with -46.50% for QTRX (price return, excluding dividends). Past performance does not predict future results.
Are Quanterix and Neuronetics in the same industry?
No. Quanterix is in the Industrials sector, while Neuronetics is in Health Care.